Using traditional HTAs to determine coverage threatens patient access to medicine

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
Traditional HTAs keep diverse patients out of the conversation

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
How HTA-based price controls could worsen health outcomes and health disparities

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
Traditional HTA methods treat everyone like the “average” patient

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...
Read More
Value assessment should include all aspects of value that matter to patients

We need to move toward a more value-driven health care system that centers around patients’ needs. Sound evidence can help guide us toward that, and we’re committed to developing tools to help...
Read More
You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...
Read More
PhRMA presents research at ISPOR 2022

Last week at the ISPOR annual international meeting, PhRMA partnered with multiple organizations committed to advancing value assessment research and methods. We worked with a range of academics,...
Read More
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Panel releases best practices in cost-effectiveness analysis

Recently, the Journal of the American Medical Association (JAMA) published findings and recommendations from the Second Panel on Cost-Effectiveness in Health and Medicine, detailing what the authors...
Read More
Who gets a seat at ICER’s table? Hint: It’s not patients

As we continue the move toward a value-driven health care system, efforts to develop tools supporting patient decision-making will play a central role. These tools, including emerging value...
Read More